Escape from TGF‐β‐induced senescence promotes aggressive hallmarks in epithelial hepatocellular carcinoma cells
Authors:
- Minenur KalyoncuMKMinenur Kalyoncu
- Dilara DemirciDilara Demirci
- Sude ErisSESude Eris
- Bengisu DayancBDBengisu Dayanc
- Ece CakirogluECEce Cakiroglu
- Merve BasolMBMerve Basol
- Merve UysalMerve Uysal
- Gulcin Cakan‐AkdoganGCGulcin Cakan‐Akdogan
- Fang LiuFLFang Liu
- Mehmet OzturkMOMehmet Ozturk
- Gökhan KarakülahGKGökhan Karakülah
- Serif SenturkSSSerif Senturk
Open Access
- 14 March 2025
- journal article
- Published by Wiley in Molecular Oncology
- Vol. 19 (9) , 2594-2618
Abstract
Transforming growth factor‐β (TGF‐β) signaling and cellular senescence are key hallmarks of hepatocellular carcinoma (HCC) pathogenesis. Despite provoking senescence‐associated growth arrest in epithelial HCC cells, elevated TGF‐β activity paradoxically correlates with increased aggressiveness and poor prognosis in advanced tumors. Whether the transition between these dichotomous functions involves modulation of the senescence phenotype during disease progression remains elusive. Exploiting the epithelial HCC cell line Huh7 as a robust model, we demonstrate that chronic exposure to TGF‐β prompts escape from Smad3‐mediated senescence, leading to the development of TGF‐β resistance. This altered state is characterized by an optimal proliferation rate and the acquisition of molecular and functional traits of less‐differentiated mesenchymal cells, coinciding with differential growth capacity in 2D and 3D culture conditions, epithelial‐to‐mesenchymal transition (EMT), and increased invasiveness in vitro, and metastasis in vivo. Mechanistically, resistant cells exhibit defective activation and nuclear trafficking of Smad molecules, particularly Smad3, as ectopic activation of the TGF‐β/Smad3 axis is able to reinstate TGF‐β sensitivity. An integrated transcriptomic landscape reveals both shared and distinct gene signatures associated with senescent and TGF‐β resistant states. Importantly, genetic ablation and molecular studies identify microtubule affinity regulating kinase 1 (MARK1) and glutamate metabotropic receptor 8 (GRM8) as critical modulators of the resistance phenomenon, potentially by impairing spatiotemporal signaling dynamics of Smad activity. Our findings unveil a novel phenomenon wherein epithelial HCC cells may exploit senescence plasticity as a mechanism to oppose TGF‐β anti‐tumor responses and progress towards more aggressive HCC phenotypes.Keywords
Funding Information
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu (217Z168)
- İzmir Biyotıp ve Genom Merkezi, Dokuz Eylül Üniversitesi
- Türkiye Bilimler Akademisi
- Bilim Akademisi
This publication has 78 references indexed in Scilit:
- Escape from senescence: molecular basis and therapeutic ramificationsThe Journal of Pathology, 2023
- Complex heatmap visualizationiMeta, 2022
- Systematic Analysis of Cytostatic TGF-Beta Response in Mesenchymal-Like Hepatocellular Carcinoma Cell LinesJournal of Gastrointestinal Cancer, 2021
- AMPKα-like proteins as LKB1 downstream targets in cell physiology and cancerJournal of Molecular Medicine, 2021
- Doxorubicin‐induced senescence promotes stemness and tumorigenicity in EpCAM−/CD133− nonstem cell population in hepatocellular carcinoma cell line, HuH‐7Molecular Oncology, 2021
- A mesenchymal‐like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cellsInternational Journal of Cancer, 2014
- TGF-β in progression of liver diseaseCell and tissue research, 2011
- Transforming Growth Factor-Beta Induces Senescence in Hepatocellular Carcinoma Cells and Inhibits Tumor Growth†,‡Hepatology, 2010
- Inhibition of c‐Jun NH2‐terminal kinase switches Smad3 signaling from oncogenesis to tumor‐ suppression in rat hepatocellular carcinoma†Hepatology, 2009
- CD133+ liver cancer stem cells from methionine adenosyl transferase 1A–deficient mice demonstrate resistance to transforming growth factor (TGF)-β–induced apoptosis #Hepatology, 2009